drugset / Trial / NCT04391894
A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The study was planned to be conducted in 2 parts: Part 1 to determine the efficacy and safety of ECF843 vs vehicle, followed by Part 2 with additional exploratory assessments of ECF843 vs Vehicle. Both parts of the study included a double-masked study design, with randomization stratified for subjects with Sjogren's Syndrome.
Timeline
- Start
- 2020-10-06
- Primary completion
- 2021-05-13
- Completion
- 2021-05-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ECF843 | Unknown | 0.15 mg/ml | Topical |
| Subject | ECF843 | Unknown | 0.45 mg/ml | Topical |